Goodwin advised OKRA.ai on the deal. Bird & Bird and Ropes & Gray advised Envision Pharma Group. OKRA.ai announced their acquisition by Envision Pharma Group (Envision). Envision...
Envision’s Acquisition of OKRA.ai
Amphista Therapeutics’ Series B Extension Investment
Bird & Bird has advised the Dementia Discovery Fund on the deal. The investment will enable Amphista to accelerate the application of its technology into indications...